GSTN Helpdesk handles over 56,000 taxpayer issues in one month of lockdown

Before the lockdown, on an average, GST helpdesk would receive around 8,000 to 10,000 calls every day, while around 2,000 tickets were raised on the GRP portal on a daily basis.

PTI

May 03, 2020 / 16:26 IST

GST Network Helpdesk on Sunday said it has handled over 56,000 taxpayer issues in one month since the nationwide lockdown was imposed on March 25. According to data from GSTN, over 19,552 tickets raised by taxpayers were resolved between March 25 and April 24. The highest number of tickets handled in a day was 2,766 and the highest number of calls handled was 1,776.

"However, due to the lockdown, there is a steep dip experienced in the call and ticket volume trend at GST helpdesk. The total received transactions (inflow of calls and GRP tickets) are approximately 20 per cent of the usual volume trend," GSTN said.

Before the lockdown, on an average, GST helpdesk would receive around 8,000 to 10,000 calls every day, while around 2,000 tickets were raised on the GRP portal on a daily basis.

The GST Helpdesk, whose 65 per cent of staff worked from home, was fully operational through its toll-free number from 9 am to 9 pm serving in 12 languages, it added.

GSTN CEO Prakash Kumar said help desk agents had to work from home, calls had to be routed to them at their phone and this was done in a secured manner.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show